Company Profile

Day Zero Diagnostics Inc (AKA: DZD)
Profile last edited on: 4/12/2023      CAGE: 7PXR9      UEI: KZKSJLYEAE83

Business Identifier: Integrating genome sequencing with machine learning to tackle infectious disease diagnosis and treatment
Year Founded
2016
First Award
2019
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

127 Western Avenue
Boston, MA 02134
   (857) 249-2417
   info@dayzerodiagnostics.com
   www.dayzerodiagnostics.com
Location: Single
Congr. District: 07
County: Suffolk

Public Profile

The possibility of a public health crisis due to antibiotic resistance is becoming more real particulary when such an occurence would involve severe infections: Example: sepsis - where patient can succomb quickly and before resistance can be determined. Day Zero Diagnostics - DZD - is developing rapid, whole genome sequencing-based diagnostics designed rapidly (within hours) to provide the species ID and antibiotic resistance profile of a bacterial infection within hours enduring patients can quickly be treated with the most effective antibiotic - not only saving lives but reducing the costs associated with extended episodes of care where early treatments do not work. The firm is also working on helping to control HAIs (healthcare-associated infections), where antibiotic resistant organisms can be especially dangerous. To enable rapid turnaround, the firm's epiXact service uses whole genome sequencing and their proprietary Keynome™ algorithm which uspports their being able quickly to provide infection control professionals with precise information on pathogen relatedness supporting those persons being able to make the right intervention decisions.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Key People / Management

  Jong Lee -- President & CEO, Co-founder

  Jong Lee -- President & CEO, Co-founder

  Melis Anahtar -- Scientific Co-Founder

  Amanda Billings

  Nicole Billings -- Director Lab Services

  Michelle Chen -- Research Associate

  Thomas Culp -- Associate Data Scientist

  Lisa Cunden -- Research Scientist

  Rachel Eisenhauer -- Mlsc Intern

  Tim Farrell -- Bioinformatics Engineer

  Walter Gillett -- Software Architect

  Ian Herriott -- Director of Sequencing Technologies

  Miriam Huntley -- CTO, Co-founder

  Paul Knysh -- Research Scientist Machine Learning

  Michael Kumcu -- Research Associate II

  Doug Kwon -- Chief Scientific Officer and Co-Founder

  Jae Hyeon Lee -- Senior Research Scientist Machine Learning

  Dougal Maclaurin -- Scientific Co-Founder

  Cabell Maddux -- Director Software Engineering

  Rachel Martin -- Research Associate

  Zach Munro -- Software Engineer

  Imaly Nanayakkara -- Research Scientist

  Febriana Pangestu -- Genomics Sequencing Technician

  Jeremy Parrish -- Controller

  Poornima Ramaraj -- Associate Data Scientist

  Zoe Rogers -- Clinical Affairs Manager

  Mohamad Sater -- Senior Computational Biologist

  Nidhi Shah -- Research Associate II

  Chiahao (Kevin) Tsui -- Senior Research Scientist

  Jason Wittenbach -- Director of Data Science

Company News

There are no news available.